
Healite II™ by Aestellar
Low-Level Light Therapy Reimagined Through Science, Comfort, and Innovation
At Aestellar, we believe that aesthetic innovation must go beyond visible results—it should also optimize healing, reduce downtime, and elevate patient experience. That’s where Healite II™ comes in: a clinically advanced, non-invasive medical aesthetic device that uses Low-Level Light Therapy (LLLT) to accelerate cellular recovery, reduce inflammation, and enhance the outcome of both standalone and adjunctive treatments.
This powerful yet gentle facial treatment device combines cutting-edge technology with therapeutic comfort, making it an ideal addition to any aesthetic practice focused on safety, performance, and patient satisfaction.
What is Healite II™?
Healite II™ is a next-generation LED (Light Emitting Diode) system developed using advanced 830nm near-infrared light and proprietary Optical Lens Array Technology (OLAT). This device delivers consistent and deeply penetrating phototherapy to modulate skin function at the cellular level—without causing thermal or mechanical trauma.
With FDA-cleared 830nm wavelength and precision-tuned fluence levels, Healite II™ is the ultimate enhancement for clinical protocols, including:
- Reducing post-treatment erythema and edema
- Supporting wound healing
- Relieving minor joint and muscle discomfort
- Improving local blood circulation
- Enhancing recovery from microneedling, RF, laser, or injectables
Whether used as a standalone session or as an adjunct to other procedures, Healite II™ helps maximize both results and patient well-being.
How Does Healite II™ Work?
Healite II™ delivers photobiomodulation through low-level light at 830nm. This wavelength penetrates deeply into the skin, stimulating ATP production, promoting cellular regeneration, and reducing inflammatory responses. Unlike high-powered laser systems, this medical aesthetic device is completely non-ablative—making it safe for all skin types and suitable for regular use.
The patented OLAT collimation optics ensures that light is evenly distributed across the treatment area, while integrated cooling and comfort-focused design make each session feel spa-like and relaxing.
Clinical Benefits of Healite II™
Practices that integrate Healite II™ as part of their treatment portfolio consistently report:
- Up to 50% reduction in post-procedure redness and swelling
- Enhanced wound healing and faster recovery from aesthetic treatments
- Relaxing, hands-free sessions with no downtime required
- Effective pain relief for patients experiencing joint or muscle tension
- Elevated patient satisfaction and stronger brand differentiation
More importantly, Healite II™ delivers measurable improvements that support a wide range of treatment goals—from skin rejuvenation to inflammation control—without additional risk.
Why Choose Healite II™ with Aestellar?
As a key product in the Aestellar portfolio of medical aesthetic devices, Healite II™ reflects our commitment to advancing science-backed beauty solutions. It empowers practitioners with a tool that adds value to every session—helping clinics build trust, deliver better outcomes, and stand out in a competitive market.
Whether you’re expanding your treatment offerings or upgrading patient aftercare protocols, Healite II™ is the smart, proven choice in aesthetic innovation.
Before & After









What Providers Are Saying
Won-Serk Kim, M.D., Ph.D.
Dermatologist, Seoul, Korea
“HEALITE II is a useful adjunct to almost any aesthetic treatment. It is so important now that I couldn’t imagine practicing aesthetic medicine without it.”
Clinical Papers
Healite II
Is Light-emitting Diode Phototherapy (LED-LLLT) Really Effective?
Publication Date: September 1, 2011
Publisher: Laser Therapy
Author(s): Won-Serk Kim; R Glen Calderhead
Healite II
830 nm light-emitting diode (led) phototherapy significantly reduced return-to-play in injured university athletes: a pilot study
Publication Date: March 31, 2016
Publisher: Laser Therapy
Author(s): John Foley; David B Vasily; Jeanna Bradle; Catharine Rudio; R Glen Calderhead
Healite II
Skin Reactions After Photodynamic Therapy are Unaffected by 839nm Photobiomodulation Therapy: A Randomized,Double-Blind, Placebo-Controlled, Clinical Trial
Publication Date: May 26, 2017
Publisher: Lasers in Surgery and Medicine
Author(s): Christiane Bay; Anne-Cathrine Vissing; Daniel Thaysen-Petersen; Catharina Margrethe Lerche; Katrine Togsverd-Bo; Jakob Heydenreich; Merete Haedersdal
Frequently Asked Questions